These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5420431)

  • 21. [Coagulation factors. Indications and applications].
    Stampfli K; Hartmann S
    Ther Umsch; 1984 Aug; 41(8):571-5. PubMed ID: 6437000
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG
    Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of factor VIII inhibitor in three non-hemophiliac patients].
    Kiguchi T; Niiya K; Yamawaki Y; Shima M; Harada M
    Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation findings in rats with experimental hypersplenism and their changes after splenectomy and after administration of adrenaline.
    Pudlák P; Farská I; Brabec V; Pospísilová V
    Thromb Diath Haemorrh; 1970 Jun; 23(3):593-600. PubMed ID: 5432195
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnostic and therapeutic measures in congenital blood coagulation disorders].
    Eggert JH
    Dtsch Zahnarztl Z; 1982 Nov; 37(11):877-84. PubMed ID: 6816566
    [No Abstract]   [Full Text] [Related]  

  • 26. [Successful treatment of acquired F:VIII C inhibitor after delivery using plasmapheresis and high doses of immunoglobulins].
    Belić A; Pejin D; Canak V; Felle D; Lucić A
    Med Pregl; 1994; 47(9-10):359-61. PubMed ID: 7565328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of factor VIII versus nonspecific inhibitors.
    Goldsmith JC
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):3-6. PubMed ID: 8480195
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dental surgery in the coagulopathic patient. 4. General therapy of hemorrhagic diseases].
    Nardi P; Grandini R; Bertolai R
    G Stomatol Ortognatodonzia; 1989; 8(2):25-8. PubMed ID: 2534997
    [No Abstract]   [Full Text] [Related]  

  • 29. [Spontaneous ecchymosis disclosing acquired factor VIII inhibitor].
    Bayrou O; Deschamps A; Laurian C; Braunstein C; Leynadier F
    Ann Dermatol Venereol; 1993; 120(8):546-8. PubMed ID: 8304713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Factor VIII inhibitors].
    Albores Núñez MI; Pérez Llanderal JA; Telenti Vigón A
    Rev Clin Esp; 1968 Apr; 109(2):129-36. PubMed ID: 5739637
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on an acquired anticoagulant directed against factor 8.
    Hougie C
    J Lab Clin Med; 1967 Sep; 70(3):384-92. PubMed ID: 6038544
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood plasma fractions for the treatment of coagulation disorders. II. Production and clinical use of factor VIII containing preparations].
    Richter K
    Z Gesamte Inn Med; 1967 Aug; 22(15):451-6. PubMed ID: 5592694
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunocoagulopathies as a possible cause of acquired hemorrhagic diathesis].
    Klare M; Möller T; Hanke P; Weller P; Seige K
    Z Gesamte Inn Med; 1983 May; 38(10):277-80. PubMed ID: 6412468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired hemophilia secondary to factor VIII inhibitors after pregnancy.
    Dhôte R; Stieltjes N; Thevenot T; Permal S; Pernin N; Molho P; Christoforov B
    Ann Med Interne (Paris); 1998 Sep; 149(5):300-2. PubMed ID: 9791567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of the weak factor VIII inhibitors].
    Mayer G; Noel G; Waitz R
    Acta Haematol; 1969; 42(1):27-41. PubMed ID: 4982619
    [No Abstract]   [Full Text] [Related]  

  • 36. Care of the critically ill child: the problem of disseminated intravascular coagulation.
    Hathaway WE
    Pediatrics; 1970 Nov; 46(5):767-73. PubMed ID: 5481077
    [No Abstract]   [Full Text] [Related]  

  • 37. Postpartum factor VIII inhibitors. Report of two cases with special reference to the efficacy of various treatments.
    Hauser I; Gisslinger H; Locker G; Elbl W; Kyrle PA; Pabinger I; Lechner K
    Wien Klin Wochenschr; 1993; 105(12):355-8. PubMed ID: 8333206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Statistic considerations in the treatment of patients with coagulation disorders: 2 methods of approach].
    Moro GF; Campolongo F
    Riv Ital Stomatol; 1983; 52(7-8):589-92. PubMed ID: 6236541
    [No Abstract]   [Full Text] [Related]  

  • 39. [Directions for blood component therapy in blood coagulation disorders].
    Rasche H
    Klin Anasthesiol Intensivther; 1980; 21():136-51. PubMed ID: 6779052
    [No Abstract]   [Full Text] [Related]  

  • 40. Acquired factor VIII inhibitor in a patient with malignant lymphoma.
    Wenz B; Friedman G
    Am J Med Sci; 1974 Nov; 268(5):295-9. PubMed ID: 4617504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.